Wells Fargo’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Wells Fargo's PRAX Position: Q3 2026 in Review
Wells Fargo reduced its Praxis Precision Medicines (PRAX) stake by 35% in Q3 2026, selling an estimated $3.27M and leaving 18,002 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2623.
Wells Fargo first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. The position peaked at $9.34M in Q2 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Wells Fargo held 18,002 shares of Praxis Precision Medicines worth $5.24M as of Q3 2026.
- Wells Fargo sold 9,887 Praxis Precision Medicines shares in Q3 2026, an estimated $3.27M.
- Praxis Precision Medicines made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #2623 holding.
- Wells Fargo first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
- Wells Fargo's Praxis Precision Medicines position peaked at $9.34M in Q2 2026.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.